BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3142447)

  • 21. Carbonic anhydrase III as a serum marker for diagnosis of rhabdomyolysis.
    Syrjälä H; Vuori J; Huttunen K; Väänänen HK
    Clin Chem; 1990 Apr; 36(4):696. PubMed ID: 2108827
    [No Abstract]   [Full Text] [Related]  

  • 22. [Myoglobin radioimmunoassay: experience of the diagnosis of skeletal muscle disorders (author's transl)].
    Kiessling WR; Pflughaupt KW
    Arch Psychiatr Nervenkr (1970); 1981; 230(1):49-54. PubMed ID: 7259483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased serum myosin light chain 3 level in neuromuscular diseases.
    Konagaya M; Konagaya Y; Horikawa H; Takayanagi T
    Muscle Nerve; 1987 Jun; 10(5):415-21. PubMed ID: 3112571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The significance of simultaneous estimation of serum creatine kinase and myoglobin in neuromuscular diseases.
    Diószeghy P; Mechler F
    J Neurol; 1988 Jan; 235(3):174-6. PubMed ID: 3367167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myoglobin/carbonic anhydrase III ratio: highly specific and sensitive early indicator for myocardial damage in acute myocardial infarction.
    Vuori J; Syrjälä H; Väänänen HK
    Clin Chem; 1996 Jan; 42(1):107-9. PubMed ID: 8565206
    [No Abstract]   [Full Text] [Related]  

  • 26. The significance of the estimation of serum myoglobin in neuromuscular diseases.
    Hische EA; van der Helm HJ
    J Neurol Sci; 1979 Oct; 43(2):243-51. PubMed ID: 512682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle damage induced by stretch-shortening cycle exercise.
    Kyröläinen H; Takala TE; Komi PV
    Med Sci Sports Exerc; 1998 Mar; 30(3):415-20. PubMed ID: 9526888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical applications of muscle enzymes and proteins.
    Wu AH; Perryman MB
    Curr Opin Rheumatol; 1992 Dec; 4(6):815-20. PubMed ID: 1457275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of immunoreactive carbonic anhydrase III in various human tissues determined by a sensitive enzyme immunoassay method.
    Kato K; Mokuno K
    Clin Chim Acta; 1984 Aug; 141(2-3):169-77. PubMed ID: 6435916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphomannosyl receptors of lysosomal enzymes of skeletal muscle in neuromuscular diseases.
    Salminen A; Marjomäki V; Tolonen U; Myllylä VV
    Acta Neurol Scand; 1988 Jun; 77(6):461-7. PubMed ID: 2841820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise-induced necrotic muscle damage and enzyme release in the four days following prolonged submaximal running in rats.
    Komulainen J; Vihko V
    Pflugers Arch; 1994 Oct; 428(3-4):346-51. PubMed ID: 7816556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of myoglobin/carbonic anhydrase III ratio as a marker for myocardial damage in patients with renal failure.
    Vuori J; Huttunen K; Vuotikka P; Väänänen HK
    Clin Chim Acta; 1997 Sep; 265(1):33-40. PubMed ID: 9352127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbonic anhydrase-III immunohistochemical localization in human skeletal muscle.
    Shima K; Tashiro K; Hibi N; Tsukada Y; Hirai H
    Acta Neuropathol; 1983; 59(3):237-9. PubMed ID: 6221502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Running-induced muscle injury and myocellular enzyme release in rats.
    Komulainen J; Kytölä J; Vihko V
    J Appl Physiol (1985); 1994 Nov; 77(5):2299-304. PubMed ID: 7868448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Serum enzymatic activity in neuromuscular diseases].
    Strumień M
    Neurol Neurochir Pol; 1975; 9(1):1-5. PubMed ID: 1121344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approach to asymptomatic creatine kinase elevation.
    Moghadam-Kia S; Oddis CV; Aggarwal R
    Cleve Clin J Med; 2016 Jan; 83(1):37-42. PubMed ID: 26760521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of diurnal fluctuations between serum myoglobin level and creatine kinase activities in neuromuscular diseases].
    Konagaya M; Konagaya Y; Horikawa H; Takayanagi T
    Rinsho Shinkeigaku; 1984 Mar; 24(3):293-9. PubMed ID: 6540636
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
    Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The serum-creatine phosphokinase (CPK) activity in amyotrophic lateral sclerosis (ALS) and other neurogenous muscular atrophies with regard to differential diagnostic aspects].
    Koufen H; Consbruch U
    Nervenarzt; 1970 Dec; 41(12):599-603. PubMed ID: 4924032
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.